Chilean Ministers meet Sinovac executives over potential vax production site
By IANS |
0 Views
Rs 35k crore for vaccines lone positive aspect of budget: YSRCP (Xinhua/ians). Image Source: IANS News
Santiago, July 25 : Chilean Ministers have met executives from the Chinese company Sinovac over the pharmaceutical firm s plan to create a potential vaccination production site.
The group visited a plot of land 28 km north of the city of Antofagasta on Friday, which could be the site of a future production plant for Covid-19 vaccines, the Chilean Ministry of Health said on Saturday.
It is estimated that the construction of the plant would be completed by the end of 2022, allowing operation to begin from 2023, said the Ministry, adding it would require an investment of about $60 million, reports Xinhua news agency.
Chilean ministers meet with Sinovac executives over potential vaccine production site msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Just 18 months after the start of the coronavirus pandemic, Egyptian vaccine maker Vacsera passed a milestone.
Last weekend, the company celebrated the production of its first million doses of a Covid-19 vaccine developed by Chinese firm Sinovac.
A similar effort is under way at the other end of the continent, where South Africa’s Aspen Pharmacare is producing Johnson & Johnson’s coronavirus shots. The two companies signed an agreement in November and the first batch was produced in May.
Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.
A Covid-19 vaccine by China's Sinovac Biotech has been approved for emergency use by the World Health Organization, adding a globally recognised vote of confidence to a jab that's been at the forefront of China's vaccine exports worldwide. The WHO announced its decision to clear the vaccine, dubbed CoronaVac, for an emergency-use license on Tuesday, making it the second vaccine from a Chinese drug maker to receive the listing in less than a.
Science s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation
Beijing-based Sinovac, which makes a COVID-19 vaccine from inactivated virus, has efficacy trials underway in Brazil, Turkey, and Indonesia but not in China.
PHOTO: REUTERS/THOMAS PETER
The first people in the world to receive a COVID-19 vaccine were not part of a clinical trial. No TV stations or newspapers covered the historic event. No company issued a statement.
On 29 February, less than 2 months after the world awakened to the threat of the new disease, virologist Chen Wei, a major general in China s army, and six military scientists on her team stood in front of a Chinese Communist Party flag and received injections of an experimental COVID-19 vaccine. Chen, a national hero for her work on Ebola vaccines, had come to the initial center of the pandemic, Wuhan, with her group from the Academy of Medical Military Sciences, in part to help make the candidate vaccine with pharmaceu